ICD-10-CM Billable Code

D29.22

Benign neoplasm of left testis

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign neoplasm of the left testis is a non-cancerous growth that develops in the testicle on the left side. Also known as a benign testicular tumor, this condition involves abnormal cell growth but does not spread to other parts of the body. Although generally not life-threatening, it is important to monitor and manage this condition with the guidance of a healthcare professional to ensure proper treatment and peace of mind.

Causes & Symptoms

Clinical Causes: Genetic predisposition may play a role in the development of benign testicular tumors. Hormonal imbalances, particularly involving testosterone, could contribute to abnormal cell growth. Environmental factors, including exposure to certain chemicals or toxins, might increase risk. Previous testicular injury or inflammation may be associated with benign growths. In some cases, benign testicular tumors develop without a clear cause.

Key Symptoms: A painless lump or swelling in the testicle is the most common symptom. A feeling of heaviness or discomfort in the scrotum. Size increase of the testis over time. Rarely, pain or tenderness may occur if the tumor causes pressure or irritation. Sometimes, no noticeable symptoms are present, and the tumor is found during routine examinations or imaging tests.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of a benign neoplasm of the left testis involves several steps to confirm the nature of the growth and rule out malignancy. Typical diagnostic procedures include: - Physical Exam: A healthcare provider may palpate the testicles to detect any lumps or abnormalities. - Ultrasound Imaging: This non-invasive test helps visualize the testicular tissue and differentiate between benign and potentially malignant tumors. - Blood Tests: Certain markers such as alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH) can assist in assessing tumor activity, although they are more specific for malignancies. - Surgical Evaluation: In some cases, a biopsy or surgical removal of the tumor might be necessary for definitive diagnosis.

Treatment Protocols: Treatment strategies for a benign neoplasm of the left testis typically focus on removing the tumor while preserving testicular function whenever possible. Options include: - Testicular Surgery (Tumor Removal): The primary treatment involves surgically excising the benign growth, often through a procedure called testis-sparing surgery. - Regular Monitoring: Post-treatment, periodic follow-up examinations and ultrasounds are essential to monitor for any recurrence or new growth. - Adjuvant Therapy: Usually not required for benign tumors, but ongoing surveillance is advised. - Management of Symptoms: If any discomfort or swelling persists, supportive care or additional treatment may be recommended. It’s important to consult with a healthcare professional to determine the most appropriate approach based on individual circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D29.22 a billable ICD-10 code?
Yes, D29.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D29.22?
Clinical documentation must specify the nature of Benign neoplasm of left testis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

testis neoplasm